Health and Safety
Regulatory Provisions Concerning Public Health
CHAPTER 30N. Lyme Disease Information [Expires Aug. 21, 2022].
(a) A health-care provider who draws the blood of a patient to perform a laboratory test for Lyme disease shall provide the patient with the following written notice, or a substantially similar notice, at the time the patient’s blood is drawn:
“Your health-care provider has ordered a laboratory test for the presence of Lyme disease for you. Current laboratory testing for Lyme disease, like all standard laboratory tests, can result in false negatives and false positives. If you continue to experience unexplained symptoms, you should contact your health-care provider and inquire about the appropriateness of retesting or initial or additional treatment.”
(b) Notwithstanding any other law, this section does not create a cause of action or create a standard of care, obligation, or duty that provides a basis for a cause of action.
(c) The information required by this section or evidence that a person violated this section is not admissible in a civil, judicial, or administrative proceeding.82 Del. Laws, c. 210, § 1;
82 Del. Laws, c. 210, § 1;